Chugai's Xeloda Obtains Additional Indications In Japan
This article was originally published in The Pink Sheet Daily
Executive Summary
To maintain its lead in the Japanese oncology market, Chugai creates the Chugai Academy for Advanced Oncology, to promote translational research, convene forums, and sponsor cancer research.